Hostname: page-component-76fb5796d-qxdb6 Total loading time: 0 Render date: 2024-04-29T13:21:14.207Z Has data issue: false hasContentIssue false
  • English
  • Français

Treatment of Bipolar Disorder During the Postpartum Period

Published online by Cambridge University Press:  07 November 2014

Adele C. Viguera
Adele C. Viguera*
Affiliation:
Dr. Viguera is associate director of the Perinatal and Reproductive Psychiatry Program at, Massachusetts General Hospitaland assistant professor of psychiatry at Harvard Medical School in Boston.
Get access Rights & Permissions [Opens in a new window]

Abstract

The presentations and clinical courses of patients with bipolar disorder differ greatly by gender. In addition, medical therapy must be tailored differently for men and women because of emerging safety concerns unique to the female reproductive system. In November 2005, these topics were explored by a panel of experts in psychiatry, neurology, and reproductive health at a closed roundtable meeting in Dallas, Texas. This clinical information monograph summarizes the highlights of that meeting.

Compared to men with bipolar disorder, women have more pervasive depressive symptoms and experience more major depressive episodes. They are also at higher risk for obesity and certain other medical and psychiatric comorbidities. Mood changes across the menstrual cycle are common, although the severity, timing, and type of changes are variable. Bipolar disorder is frequently associated with menstrual abnormalities and ovarian dysfunction, including polycystic ovarian syndrome. Although some cases of menstrual disturbance precede the treatment of bipolar disorder, it is possible that valproate and/or antipsychotic treatment may play a contributory role in young women.

Pregnancy does not protect against mood episodes in untreated women. Maintenance of euthymia during pregnancy is critical because relapse during this period strongly predicts a difficult postpartum course. Suspending therapy in the first months of pregnancy may be an option for some women with mild-to-moderate illness, or those with a long history of euthymia during pre-pregnancy treatment. However, a mood stabilizer should be reintroduced either in the later stages of pregnancy or in the immediate postpartum period. Preliminary data suggest that fetal exposure to some mood stabilizers may raise the risk of major congenital malformations and neurodevelopmental delays. For women planning to become pregnant, clinicians may consider switching to other drugs before conception. The value and drawbacks of breastfeeding during treatment must be considered in partnership with the patient, with close monitoring of nursing infants thereafter. The risks and benefits of medical treatment for women with bipolar disorder should be carefully reconsidered at each stage of their reproductive lives, with a flexible approach that is responsive to the changing needs of patients and their families.

Type
Research Article
Information
CNS Spectrums , Volume 11 , Issue S5 , May 2006 , pp. 13 - 14
Copyright
Copyright © Cambridge University Press 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Kendell, RE, Chalmers, JC, Platz, C. Epidemiology of puerperal psychoses. Br J Psychiatry. 1987;150:662–673.CrossRefGoogle ScholarPubMed
2.Leibenluft, E. Women with bipolar illness: clinical and research issues. Am J Psychiatry. 1996;153:163–173.Google ScholarPubMed
3.Viguera, AC, Cohen, LS, Baldessarini, RJ, Nonacs, R. Managing bipolar disorder during pregnancy: weighing the risks and benefits. Can J Psychiatry. 2002;47:426–436.CrossRefGoogle ScholarPubMed
4.Jones, I, Craddock, N. Bipolar disorder and childbirth: the importance of recognizing risk. Br J Psychiatry. 2005;186:453–454.CrossRefGoogle Scholar
5.Cohen, LS, Altshuler, LL. Pharmacologic management of psychiatric illness during pregnancy and the postpartum period. Psychiatr Clin North Am. 1997;4:21–60.Google Scholar
6.Jones, I, Craddock, N. Familiarity of the puerperal trigger in bipolar disorder: results of a family study. Am J Psychiatry. 2001;158:913–917.CrossRefGoogle Scholar
7.Viguera, AC, Nonacs, R, Cohen, LS, et al.Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry. 2000;157:179–184.CrossRefGoogle ScholarPubMed
8.Robertson, E, Jones, I, Hague, S, et al.Risk of puerperal and non-puerperal recurrence of illness following bipolar affective puerperal (postpartum) psychosis. Br J Psychiatry. 2005;186:258–259.CrossRefGoogle Scholar
9.Braftos, O, Haug, HJ. Pueroral mental disorders in manic depressive females. Acta Psychiatr Scand. 1966;42:285–294.Google Scholar
10.Reich, T, Winokur, G. Postpartum psychosis in patients with manic depressive disease. J Nerv Ment Dis. 1970;151:60–68.CrossRefGoogle Scholar
11.Brockington, IF, Cernik, KF, Schofield, EM, et al.Puerperal psychosis: phenomena and diagnosis. Arch Gen Psychiatry. 1981;38:829–833.CrossRefGoogle ScholarPubMed
12.Blehar, M, Depaulo, J, Gershon, E, Reich, T, Simpson, S, Nurnberger, J. Women with bipolar disorder: findings from the NIMH genetics initiative sample. Psychpharm Bull. 1988;34:239–243.Google Scholar
13.Freeman, MP, Wosnitzer Smith, K, Freeman, S, McElroy, A, Kmetz, GF, Wright, R, Keck, PE. The Impact of reproductive events on the course of bipolar disorder in women. J Clin Psychiatry. 2002;63:284–287.CrossRefGoogle ScholarPubMed
14.Chaudron, LH, Pies, RW. The relationship between postpartum psychosis and bipolar disorder: a review. J Clin Psychiatry. 2003;64:1284–1292.CrossRefGoogle ScholarPubMed
15.Klompenhouwer, J, van Hulst, A. Classification of postpartum psychosis: a study of 250 mother and baby admissions in the Netherlands. Acta Psychaitr Scand. 1991;84:255–261.CrossRefGoogle ScholarPubMed
16.Robling, SA, Paykel, ES, Dunn, VJ, Abbott, R, Katona, C. Long-term outcome of severe puerperal psychiatric illness: a 23 year follow-up study. Psychol Med. 2000;30:1263–1271.CrossRefGoogle ScholarPubMed
17.American Psychiatric Association. Practice guidelines for the treatment of patients with bipolar disorder, revision. Am J Psychiatry. 2002;159:1–50.Google Scholar
18.Yonkers, KA, Wisner, KL, Stowe, Z, et al.Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry. 2004;161:608–620.CrossRefGoogle ScholarPubMed
19.Cohen, LS, Sichel, DA, Robertson, LM, Heckscher, E, Rosenbaum, JF. Postpartum prophylaxis for women with bipolar disorder. Am J Psychiatry. 1995;152:1641–1645.Google ScholarPubMed
20.Stewart, DE, Klompenhouwer, JL, Kendall, RE, van Hulst, AM. Prophylactic lithium in puerperal psychosis: experience of three centers. Br J Psychiatry. 1991;158:393–397.CrossRefGoogle Scholar
21.Austin, MPV. Puerperal affective psychosis: is there a case for lithium prophylaxis? Br J Psychiatry. 1992;161:692–694.CrossRefGoogle Scholar
22.van Gent, EM, Verhoeven, WMA. Bipolar illness, lithium prophylaxis, and pregnancy. Pharmacopsychiatry. 1992;25:187–191.CrossRefGoogle ScholarPubMed
23.Wisner, KL, Hanusa, BH, Peindl, KS, Perel, JM. Prevention of postpartum episodes in women with bipolar disorder. Biol Psychiatry. 2004;56:592–596.CrossRefGoogle ScholarPubMed
24.Ahokas, A, Aito, M, Rimon, R. Positive treatment effect of estradiol in postpartum psychosis: a pilot study. J Clin Psychiatry. 2000;61:166–169.CrossRefGoogle ScholarPubMed
25.Kumar, C, McIvor, RJ, Davies, T, et al.Estrogen administration does not reduce the rate of recurrence of affective psychosis after childbirth. J Clin Psychiatry. 2003;64:112–118.CrossRefGoogle Scholar
26.Burt, VK, Suri, R, Altshuler, L, Stowe, Z, Hendrick, V, Muntean, E. The use of psychotropic medications during breastfeeding. Am J Psychiatry. 2001;158:1001–1009.CrossRefGoogle ScholarPubMed
27.Chaudron, LH, Jefferson, J. Mood stabilizers during breastfeeding: a review. J Clin Psychiatry. 2000;61:79–90.CrossRefGoogle ScholarPubMed
28.American Academy of Pediatrics. Committee on Drugs. The transfer of drugs and otherchemicals into human milk. Pediatrics. 2001;108:776–789.CrossRefGoogle Scholar
29.Crawford, P. Best practice guidelines for the management of women with epilepsy. Epilepsia. 2005;46(suppl 9):117–124.CrossRefGoogle ScholarPubMed
30.Llewellyn, A, Stowe, Z, Strader, JR. The use of lithium and management of women with bipolar disorder during pregnancy and lactation. J Clin Psychiatry. 1998;59(suppl 6):57–64.Google ScholarPubMed
31.Viguera, AC, Newport, DJ, Ritchie, J, et al.Lithium and lactation. Poster presented at: 158th Annual Meeting of the American Psychiatric Association; May 21-25, 2005; Atlanta, GA.Google Scholar
32.Moretti, ME, Koren, G, Verjee, Z, Ito, S. Monitoring lithium in breast milk: an individualized approach for breast-feeding mothers. Ther Drug Monit. 2003;25:364–366.CrossRefGoogle ScholarPubMed
33.Viguera, AC, Cohen, LS, Reminick, AM, et al.Anticonvulsants in pregnancy and lactation: differences in attitudes and practice patterns among neurologists vs. psychiatrists. Poster presented at: 157th Annual Meeting of the American Psychiatric Association; May 1-6, 2004; New York, NY.Google Scholar